Replies to post #2635 on Theralase Technologies Inc (TLTFF)

[Geo2014]

Phase 1 clinical trials are not efficacy trials, period. In this instance, the sponsor is treating subjects with the disease state, so yes, there is an opportunity for them to make some initial educated guesses regarding efficacy as they move to Phase 2. It is NOT a primary outcone data point.

I'm done trying to explain this.